Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (TA929)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 1 November 2023
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (TA902)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 21 June 2023
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal) (TA790)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 May 2022
Empagliflozin for treating chronic heart failure with reduced ejection fraction (TA773)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 March 2022
Sodium zirconium cyclosilicate for treating hyperkalaemia (TA599)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 24 January 2022Published: 4 September 2019
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure (IPG711)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 November 2021
Acute heart failure: diagnosis and management (CG187)Product type:GuidanceProgramme:Clinical guidelineLast updated: 17 November 2021Published: 8 October 2014
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal) (TA731)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 September 2021
ENDURALIFE powered CRT-D devices for treating heart failure (MTG33)Product type:GuidanceProgramme:Medical technologies guidanceLast updated: 21 July 2021Published: 17 March 2017
Permanent His-bundle pacemaker implantation for treating heart failure (IPG694)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 5 May 2021
Dapagliflozin for treating chronic heart failure with reduced ejection fraction (TA679)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 February 2021
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease (IPG677)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 5 August 2020
Patiromer for treating hyperkalaemia (TA623)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 February 2020
Cardiac contractility modulation device implantation for heart failure (IPG655)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 June 2019
Percutaneous mitral valve leaflet repair for mitral regurgitation (IPG649)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 29 May 2019
Chronic heart failure in adults: diagnosis and management (NG106)Product type:GuidanceProgramme:NICE guidelinePublished: 12 September 2018
Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure (IPG602)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 20 December 2017
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction (TA388)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 April 2016
Normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death (IPG549)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 February 2016
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation (IPG516)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 March 2015
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (TA314)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 June 2014
Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults (IPG482)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 March 2014
Ivabradine for treating chronic heart failure (TA267)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 November 2012
Percutaneous mitral valve annuloplasty (IPG352)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 July 2010
Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery (IPG177)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 June 2006
Partial left ventriculectomy (the Batista procedure) (IPG41)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 February 2004
TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart failure (MIB298)Product type:AdviceProgramme:Medtech innovation briefingPublished: 31 May 2022
The OPTIMIZER smart system for managing heart failure (MIB186)Product type:AdviceProgramme:Medtech innovation briefingPublished: 27 June 2019
Remote ECG interpretation consultancy services for cardiovascular disease (MIB152)Product type:AdviceProgramme:Medtech innovation briefingPublished: 27 July 2018
CentriMag for heart failure (MIB92)Product type:AdviceProgramme:Medtech innovation briefingPublished: 18 January 2017
The AutoPulse non-invasive cardiac support pump for cardiopulmonary resuscitation (MIB18)Product type:AdviceProgramme:Medtech innovation briefingPublished: 12 February 2015
Chronic heart failure in adults (QS9)Product type:Quality standardLast updated: 10 January 2023Published: 29 June 2011
Delivering Rehabilitation EnAblement in CHronic Heart Failure (REACH-HF) in WirralProduct type:Shared learningPublished: 8 March 2021
COVID-19 ready rehabilitation for heart failure: REACH-HF can deliverProduct type:Shared learningPublished: 1 December 2020
Reducing inappropriate use of NT pro BNP: A Quality Improvement projectProduct type:Shared learningPublished: 26 February 2020
How we used a World Café as a springboard to support heart failure teams in Kent, Surrey and Sussex to implement the new NICE guidelines for chronic heart failure.Product type:Shared learningPublished: 21 June 2019
Optimising Medication in patients with Chronic Heart FailureProduct type:Shared learningPublished: 29 March 2015